What is ranitidine hydrochloride IP 150 mg used for?
Ranitidine hydrochloride 150 mg tablets are used to reduce stomach acid. This can help treat conditions where acid causes symptoms, such as heartburn and indigestion related to acid.
Common uses include:
- Relief of heartburn and acid indigestion (dyspepsia).
- Treatment of certain acid-related stomach and intestinal problems where reducing acid helps healing and symptom control (as prescribed by a clinician).
How does it work for stomach acid and burning pain?
Ranitidine is an acid-reducing medicine. It blocks histamine type-2 (H2) receptors in the stomach, which lowers acid production. With less acid, symptoms like burning in the chest (heartburn) and sour stomach can improve.
What conditions might a doctor prescribe it for?
Doctors may prescribe ranitidine for acid-related disorders, including:
- Gastric/duodenal ulcer disease (to help with healing and symptom control).
- Gastroesophageal reflux disease (GERD) symptoms, when acid reduction is needed.
- Other medically diagnosed acid-related conditions, depending on the patient’s history and symptoms.
How should patients typically take a 150 mg tablet?
Take ranitidine exactly as your prescription label or clinician directs. Dosing schedules can vary based on the condition being treated (for example, once vs. twice daily, or timing in relation to meals), so the specific instructions on your prescription matter.
Important safety note
Ranitidine has been subject to major regulatory actions and market withdrawals in many countries due to concerns about impurities. If you have ranitidine at home or are considering use, check with a pharmacist or your clinician about whether your product is still allowed where you live and what the recommended alternatives are.
Alternatives if ranitidine isn’t recommended anymore
If ranitidine isn’t suitable or available, clinicians often switch patients to other acid-reducing options (such as different H2 blockers or proton pump inhibitors) based on the exact diagnosis and symptom pattern.
Sources
- [1] DrugPatentWatch.com: https://drugpatentwatch.com